Is IDE up or down today?
IDE is down 2.20% today, last at 12.87. This stock moved -2.20% versus the prior close.
IDE · IDE
IDE (IDE) is trading at 12.87, down 2.20% on the session. Price signals are mixed — no clear one-way momentum read.
Over the past 7 days, 5 headlines skew mixed. Earnings and Macro/Market themes dominated coverage. Recent headlines haven't moved the price much yet (avg impact -1.36%).
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
IDE is down 2.20% today, last at 12.87. This stock moved -2.20% versus the prior close.
Over the past 7 days, 5 headlines skew mixed. Earnings and Macro/Market themes dominated coverage. Recent headlines haven't moved the price much yet (avg impact -1.36%). Dominant story: VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System - BioSpace (1 source, neutral) RSI is 29 — oversold (beaten down) Price below 50-day average — short-term weakness Social (demo): 41% of recent mentions lean bullish — mixed social mood.
Loaded: Feb 2026 – Jul 2026 (124 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: IDE
26/ 100 index
-13.3% vs start of window
Based on 10,964 mentions over 30d
VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System - BioSpace
Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study - BioSpace
Pulse Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study - TradingView
Nitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial - BioSpace
Voya Infrastructure, Industrials and Materials Fund Revenue Breakdown – NASDAQ:XIDEX - TradingView
Will Carlos Roberto Massa Júnior win the 2026 Brazilian presidential election?
Will Eduardo Bolsonaro win the 2026 Brazilian presidential election?